Class 2 Medicines Recall: Bristol Laboratories Limited, Amlodipine Bristol Lab 2.5 mg Tablets, EL (25)A/04
Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination.
DMRC Number: DMRC-34542920
Company name: Bristol Laboratories Limited
Product description: Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435
SNOMED Code: 38095611000001108
Details of the affected batch:
Batch Number | Expiry Date | Pack Size | First Distributed |
---|---|---|---|
MF23016 | July 2025 | 28 | 29/9/2023 |
MF23017 | July 2025 | 28 | 9/10/2023 |
MF23018 | July 2025 | 28 | 16/10/2023 |
MF23019 | July 2025 | 28 | 26/10/2023 |
Active Pharmaceutical Ingredient: amlodipine besilate
Brief description of problem:
Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination.
Advice to Healthcare Professionals:
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Advice to Patients:
No further action is required by patients as this is a Pharmacy and Wholesaler level recall. There have been no reports of patients being harmed or becoming ill from taking this medicine. Patients should continue to take medicines from this batch as prescribed by your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Company contacts for further information:
For medical information enquiries please contact: Notifications@bristol-labs.co.uk
For stock control enquiries please contact: Notifications@bristol-labs.co.uk